Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 264

The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.

Predicting Disease Severity and Outcome in COVID-19 Patients: A Review of Multiple Biomarkers

Open access
Tjendra, Youley, Al Mana, Abdulaziz F., Espejo, Andrea P., Akgun, Yamac, Millan, Nicolas C., Gomez-Fernandez, Carmen, Cray, Carolyn·2020·Archives of Pathology & Laboratory Medicine

Abstract

Context.—: An abundance of clinical reports focused on specific laboratory parameters have been reported on coronavirus disease 19 (COVID-19), but a systematic analysis synthesizing these findings has not been performed. Objective.—: To review and summarize the current available literature on the predictive role of various biomarkers in COVID-19 patients. Data Sources.—: A literature search was performed using databases including PubMed, medRxiv, and bioRxiv. A total of 72 papers were reviewed, including 54 peer-reviewed papers and 18 non–peer-reviewed preprints. Conclusions.—: Although the markers are considered nonspecific, acute-phase reactants, including C-reactive protein (CRP), ferritin, serum amyloid A (SAA), and procalcitonin, were reported as sensitive markers of acute COVID-19 disease. Significantly elevated white blood cell count; marked lymphopenia; decreased CD3, CD4, or CD8 T-lymphocyte counts; high neutrophil count; thrombocytopenia; and markedly elevated inflammatory biomarkers were associated with severe disease and the risk of developing sepsis with rapid progression. Trends observed by serial laboratory measurements during hospitalization, including progressive decrease of lymphocyte count, thrombocytopenia, elevated CRP, procalcitonin, increased liver enzymes, decreased renal function, and coagulation derangements, were more common in critically ill patient groups and associated with a high incidence of clinical complications. Elevated interleukin 6 level and markedly increased SAA were most often reported in severely and critically ill patients. Indicators of systemic inflammation, such as neutrophil to lymphocyte ratio, systemic immune-inflammation index, or COVID-19 Severity Score, may be used to predict disease severity, outcome, and mortality. Interpretation of the data reported in the studies reviewed here is limited because of the study design (mostly retrospective), limited sample size, and a lack of defined clinical criteria.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.5858/arpa.2020-0471-sa

Cites

78 of 78 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 78 references

Cited by

See all 264

Metadata

Authors
Tjendra, Y., Al Mana, A. F., Espejo, A. P., Akgun, Y., Millan, N. C., Gomez-Fernandez, C., & Cray, C.
Venue
Archives of Pathology & Laboratory Medicine
Published
2020-08-20
Volume
144
Issue
12
Pages
1465-1474
ISSN
  • 0003-9985 (ISSN-L)
  • 1543-2165
OpenAlex
W3080187318
Cited by
264
References
78
FWCI
6.13
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Predicting Disease Severity and Outcome in COVID-19 Patients: A Review of Multiple Biomarkers. https://app.cochat.ai/papers/10.5858/arpa.2020-0471-sa
The paper
Tjendra, Y., Al Mana, A. F., Espejo, A. P., Akgun, Y., Millan, N. C., Gomez-Fernandez, C., & Cray, C. (2020). Predicting Disease Severity and Outcome in COVID-19 Patients: A Review of Multiple Biomarkers. Archives of Pathology & Laboratory Medicine. https://doi.org/10.5858/arpa.2020-0471-sa

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.